A tiny diabetes drug maker in Norway decided to get into energy trading — and failed spectacularly

Vistin Pharma, known for its type-2 diabetes drug Metformin, said in March that it would try its hand at the energy market. Things didn't go to plan.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

BusinessInsider /  🏆 729. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Norway Embarks On Its Most Ambitious Transport Project YetNorway's rugged west coast features glaciers, waterfalls and fjords that are beautiful — but take a long time to navigate. A major infrastructure plan could cut travel time in half.
Lire la suite »

Norway Supreme Court to hear snow crab case with implication for oilNorway's Supreme Court will on Tuesday hear arguments on whether EU ships c...
Lire la suite »

Norway police probe Jay-Z's Tidal over listening numbersNorwegian police said on Monday they were investigating allegations that some listening numbers at Tidal Music, owned by Jay-Z, Beyonce and other stars, were artificially inflated. Tidal, which began life as Norwegian start-up Wimp, has previously dismissed the allegations and its lawyer Fredrik Berg
Lire la suite »